Study: A Medical Massage Reduced Life-Threatening Bowel Obstructions Significantly
21. Mai 2020 08:00 ET | Clear Passage Therapies
Gainesville, FL, May 21, 2020 (GLOBE NEWSWIRE) -- Bowel obstructions are a highly dangerous health condition, but a recent medical massage breakthrough is now reducing, or eliminating, these health...
Life-Saving, Life-Giving New Therapy Could Disappear Due to Coronavirus
06. Mai 2020 08:00 ET | Clear Passage Therapies
Gainesville, FL, May 06, 2020 (GLOBE NEWSWIRE) -- An all-natural therapy shown to safely improve female fertility and defeat a common killer, life-threatening bowel obstructions, may become lost to...
Adhesions: Surgery’s Hidden Killer
17. September 2019 08:00 ET | Clear Passage Therapies
Gainesville, FL, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Adhesions, the internal scars that can form after surgery, have plagued doctors for centuries. Invisible to most diagnostic tests, these powerful...
LeadingLogo.png
Leading BioSciences to Present at Planet MicroCap Showcase 2019
25. April 2019 08:05 ET | Leading BioSciences
CARLSBAD, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today...
LeadingLogo.png
Leading BioSciences to Present at Biotech Showcase 2019
02. Januar 2019 08:05 ET | Leading BioSciences
CARLSBAD, Ca., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today announced...
LeadingLogo.png
Leading BioSciences Announces Appointments of James R. Neal and James Sapirstein to Board of Directors
30. Oktober 2018 08:05 ET | Leading BioSciences
Experienced Industry Executives Provide Company with Broad Life Science Industry Expertise Including Drug Development and Commercialization CARLSBAD, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) --...
Leading BioSciences
Leading BioSciences Reports Positive Interim Results from Phase 2 Trial of LB1148 in Patients Undergoing Major Surgery
19. Juni 2018 07:05 ET | Leading BioSciences
CARLSBAD, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today...
energias.jpg
Adhesion Barrier Minimizing the Risk of Post-Operative Adhesions, to Witness CAGR of 8.6% during 2017 to 2023
10. November 2017 01:12 ET | Energias Market Research
NEW YORK, Nov. 10, 2017 (GLOBE NEWSWIRE) -- The global adhesion barrier market market is expected to witness a CAGR of 8.6%, and is projected to reach USD 1,512.9 million by 2023. The global...